期刊文献+

选择性激光小梁成形术或前列腺素类药物初始治疗开角型青光眼和高眼压症的Meta 分析 被引量:7

Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention
原文传递
导出
摘要 目的:评价选择性激光小梁成形术( SLT)或前列腺素衍生物( PGA)治疗开角型青光眼( OAG)及高眼压症( OHT )的疗效。方法文献分析。通过计算机检索 Medline (1966年1月至2012年12月),EMBASE Reviews (1974年1月至2012年12月),OVID循证医学数据库、中国生物医学文献数据库 SinoMed (1978年1月至2012年12月)及 CNKI 数据库(1999年1月至2012年12月),并采用手工检索等方法收集会议文献,纳入所有相关随机对照试验。评价所纳入研究的方法学质量后,采用RevMan 5.0软件进行Meta分析。结果共纳入3个随机对照试验,161例(231只眼)开角型青光眼或高眼压症患者。 Meta 分析结果表明,SLT组降低眼压值较PGA组少0.85 mmHg [1 mmHg=0.133 kPa;WMD=-0.85,95%CI(-1.43~-0.27);P=0.82,I2=0%];治愈成功率两组相当[OR=0.70,95%CI=(0.49~1.19);P=0.58,I2=0%];PGA组需要补充治疗的患眼所占比例较SLT组大[OR=1.11,95%CI(0.60~2.06);P=0.08,I2=61%]。结论对于开角型青光眼或高眼压症的初始治疗,SLT与PGA治疗成功率相当;SLT降低眼压值幅度较单一PGA小,与PGA相比,SLT可以减少患者抗青光眼药物的使用种类。(中华眼科杂志,2014,50:343-348) Objective To compare the efficacy of selective laser trabeculoplasty ( SLT ) versus prostaglandinanalogue ( PGA) in the treatment of open angle glaucoma ( OAG) and ocular hypertension ( OHT) . Methods Literature analysis.Systematic review of randomized controlled trials comparing SLT versus PGA , identified by searching literatures including Medline (January,1966-December, 2012), EMBASE Reviews ( January , 1974-December , 2012 ) OVID Evidence-Based Medicine Reviews ( January , 1966-December , 2012), Chinese BioMedical Literature Database SinoMed (January,1966-December, 2012), and CNKI (January,1999-December, 2012).RevMan 5.0 was used to do meta-analysis.Results Three publications reporting 3 trials, 161 participants ( 231 eyes ) with OHT or OAG were included for meta-analysis.IOP reduction favored PGA group,weighted mean difference (WMD) =-0.85 [1 mmHg=0.133 kPa;95%confidence interval (CI) ( -1.43 to -0.27), no significant heterogeneity present ( P =0.82, I2 =0%)].Success rates are equal in two groups [OR =0.70,95%CI =(0.49 to 1.19), no significant heterogeneity present (P=0.58,I2 =0%)].Eyes underwent additional antiglaumatous interventions favored SLT group,OR=1.11 [95%CI =(0.60 to 2.06), significant heterogeneity present, (P=0.08, I2 =61%) ].Conclusions As primary therapy of OAG or OHT , SLT is no more effective than PGA in success rate.IOP reduction affected by SLT is not effective than PGA.Compared with PGA , SLT can reduce the use of anti-glaucoma medications.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2014年第5期343-348,共6页 Chinese Journal of Ophthalmology
基金 卫生部临床学科重点项目(2010-439-176);教育部博士点专项基金
关键词 青光眼 开角型 高眼压 小梁切除术 激光 前列腺素类 合成 Meta分析 Glaucoma,open-angle Ocular hypertension Trabeculectomy Lasers Prostaglandins,synthetic Meta-analysis
  • 相关文献

参考文献1

共引文献14

同被引文献67

  • 1江海波,夏晓波,邓琪琳,王平宝.微穿透性小梁切除术联合羊膜植入治疗开角型青光眼的中远期疗效[J].中南大学学报(医学版),2009,34(4):356-361. 被引量:3
  • 2钱韶红,孙兴怀.选择性激光小梁成形术治疗原发性开角型青光眼[J].中华医学杂志,2007,87(2):118-120. 被引量:15
  • 3王涛,王宁利.选择性激光小梁成形术治疗原发性开角型青光眼的一年疗效观察[J].眼科,2007,16(1):37-39. 被引量:22
  • 4Neacsu A M. Receptors involved in the mechanism of action of topical prostaglandines [J]. Oftalmologia, 2009, 53(2):3-7. 被引量:1
  • 5Takagi Y, Nakajima T, Shimazaki A, et al. Pharmacoiogicai characteristics of AFP- 168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug[J]. Exp Eye Res, 2004, 78(4):767-776. 被引量:1
  • 6Sutton A, Gouws P, Ropo A. Tafluprost, a new potent prostanoid receptor agonist: a dose-response study on pharmacodynamics and tolerability in healthy volunteersfJ]. Int J Clin Pharmacol Ther, 2008,46(8):400-406. 被引量:1
  • 7Sutton A, Gilvarry A, Ropo A. A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males[J]. J Ocul Pharmacol Ther, 2007, 23(4):359-365. 被引量:1
  • 8Aihara M. Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension[J]. Clin Ophthalmol, 2010, 4:163-170. 被引量:1
  • 9Traverso C E, Ropo A, Papadia M, et al. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost[J]. J Ocul Pharmacol Ther. 2010. 26(D:97-104_. 被引量:1
  • 10Uusitalo H, Pillunat L E, Ropo A. Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double- masked phase ]lI study[J]. Acta Ophthalmol, 2010, 88(1):12-19. 被引量:1

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部